» Articles » PMID: 30169766

Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype

Overview
Journal Toxicol Sci
Specialty Toxicology
Date 2018 Sep 1
PMID 30169766
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Inorganic arsenic is a human carcinogen that can target the prostate. Accumulating evidence suggests arsenic can disrupt stem cell (SC) dynamics during the carcinogenic process. Previous work demonstrated arsenic-transformed prostate epithelial (CAsE-PE) cells can recruit prostate SCs into rapidly acquiring a cancer SC (CSC) phenotype via the secretion of soluble factors. Exosomes are small, membrane-derived vesicles that contain lipids, RNA, and proteins, and actively contribute to cancer initiation and progression when taken up by target cells. Here we hypothesized that CAsE-PE cells are recruiting SCs to a CSC-like phenotype via exosomal signaling. CAsE-PE cells secreted 700% more exosomes than parental RWPE-1 cells. CAsE-PE exosomes were enriched with oncogenic factors, including oncogenes (KRAS, NRAS, VEFGA, MYB, and EGFR), inflammation-related (cyclooxygenase-2, interleukin 1B (IL1B), IL6, transforming growth factor-β, and tumor necrosis factor-A), and apoptosis-related (CASP7, CASP9, and BCL2) transcripts, and oncogenesis-associated microRNAs. When compared with SCs cultured in exosome-depleted conditioned medium (CM), SCs cultured in CM containing CAsE-PE-derived exosomes showed increased (198%) matrix metalloproteinase activity and underwent an epithelial-to-mesenchymal transition in morphology, suggesting an exosome-mediated transformation. KRAS plays an important role in arsenic carcinogenesis. Although KRAS transcript (>24 000%) and protein (866%) levels were elevated in CAsE-PE exosomes, knock-down of KRAS in these cells only partially mitigated the CSC-like phenotype in cocultured SCs. Collectively, these results suggest arsenic impacts both exosomal quantity and cargo. Exosomal KRAS is only minimally involved in this recruitment, and additional factors (eg, cancer-associated miRNAs) likely also play a role. This work furthers our mechanistic understanding of how arsenic disrupts SC dynamics and influences the tumor microenvironment during carcinogenesis.

Citing Articles

Arsenic-induced prostate cancer: an enigma.

Mukherjee A, Gopalakrishnan A Med Oncol. 2024; 41(2):50.

PMID: 38184511 DOI: 10.1007/s12032-023-02266-5.


Periconceptional and Prenatal Exposure to Metals and Extracellular Vesicle and Particle miRNAs in Human Milk: A Pilot Study.

Howe C, Armstrong D, Muse M, Gilbert-Diamond D, Gui J, Hoen A Expo Health. 2023; 15(4):731-743.

PMID: 38074282 PMC: 10707483. DOI: 10.1007/s12403-022-00520-1.


Extracellular Vesicles altered by a Per- and Polyfluoroalkyl Substance Mixture: In Vitro Dose-Dependent Release, Chemical Content, and MicroRNA Signatures involved in Liver Health.

Carberry C, Bangma J, Koval L, Keshava D, Hartwell H, Sokolsky M Toxicol Sci. 2023; .

PMID: 37851381 PMC: 10823775. DOI: 10.1093/toxsci/kfad108.


Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures.

Pandics T, Major D, Fazekas-Pongor V, Szarvas Z, Peterfi A, Mukli P Geroscience. 2023; 45(6):3381-3408.

PMID: 37688657 PMC: 10643494. DOI: 10.1007/s11357-023-00913-3.


Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers.

Clemens Z, Wang K, Ambrosio F, Barchowsky A Toxicol Sci. 2023; 195(2):231-245.

PMID: 37527016 PMC: 10535782. DOI: 10.1093/toxsci/kfad075.


References
1.
Tokar E, Qu W, Liu J, Liu W, Webber M, Phang J . Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst. 2010; 102(9):638-49. PMC: 2864291. DOI: 10.1093/jnci/djq093. View

2.
Abd Elmageed Z, Yang Y, Thomas R, Ranjan M, Mondal D, Moroz K . Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells. 2014; 32(4):983-97. PMC: 4184251. DOI: 10.1002/stem.1619. View

3.
Bachmeier B, Boukamp P, Lichtinghagen R, Fusenig N, Fink E . Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem. 2000; 381(5-6):497-507. DOI: 10.1515/BC.2000.064. View

4.
Gupta S, Srivastava M, Ahmad N, Bostwick D, Mukhtar H . Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate. 1999; 42(1):73-8. DOI: 10.1002/(sici)1097-0045(20000101)42:1<73::aid-pros9>3.0.co;2-g. View

5.
Umezu T, Ohyashiki K, Kuroda M, Ohyashiki J . Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene. 2012; 32(22):2747-55. DOI: 10.1038/onc.2012.295. View